The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
IMpower010: Genomic profiling and clinical outcomes with adjuvant atezolizumab in early-stage non-small cell lung cancer (eNSCLC).
 
Heather Wakelee
Honoraria - Chugai Pharma
Consulting or Advisory Role - BeiGene; GlaxoSmithKline; IO Biotech; Mirati Therapeutics; OncoC4
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Helsinn Therapeutics (Inst); Merck (Inst); Seagen (Inst); Xcovery (Inst)
Travel, Accommodations, Expenses - Chugai Pharma
(OPTIONAL) Uncompensated Relationships - AstraZeneca; Genentech/Roche; Merck
 
Enriqueta Felip
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol Myers Squibb; Daiichi Sankyo Europe GmbH; Gilead Sciences; GlaxoSmithKline; ITeos Therapeutics; Johnson & Johnson/Janssen; Merck Sharp & Dohme; Novartis; Pfizer; Pierre Fabre; Regeneron; Roche; Turning Point Therapeutics
Speakers' Bureau - Amgen; AstraZeneca; Bristol Myers Squibb; Daiichi Sankyo; Genentech; Gilead Sciences; Johnson & Johnson/Janssen; Lilly; Medical Trends; Medscape; Merck Serono; Merck Sharp & Dohme; Novartis; Peervoice; Pfizer; Regeneron; Roche
Travel, Accommodations, Expenses - AstraZeneca; Janssen; Roche
Other Relationship - GRIFOLS
(OPTIONAL) Uncompensated Relationships - "ETOP IBCSG Partners" Member of the Scientific Committee; “Medical writing assistance for this abstract was provided by Nimisha H. Bhoola, PhD, of Nucleus Global, an Inizio Company, and funded by F. Hoffmann-La Roche Ltd.”; Member of the Scientific Advisory Committee -Hospital Universitari Parc Taulí-; SEOM (Sociedad Española de Oncología Médica), President from 2021-2023
 
Caicun Zhou
Leadership - IASLC BOD
Honoraria - Alice; Hengrui Therapeutics; Innovent Biologics; Lilly; MSD; QiLu Pharmaceutical; Sanofi; TopAlliance BioSciences Inc
Consulting or Advisory Role - Innovent Biologics; QiLu Pharmaceutical
 
Eric Vallieres
Honoraria - AstraZeneca; Merck; MJH Life Sciences; OMNI Health Media
Speakers' Bureau - AstraZeneca; Merck
Travel, Accommodations, Expenses - AstraZeneca; Merck
 
Martin Reck
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; BioNTech SE; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; GlaxoSmithKline K.K.; IO Biotech; IO Biotech; Lilly; Merck Serono; Mirati Therapeutics; MSD Oncology; Novartis; Pfizer; Roche/Genentech; Samsung Bioepis; Sanofi/Regeneron
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; Merck Serono; Mirati Therapeutics; MSD Oncology; Novartis; Pfizer; Roche/Genentech; Sanofi/Aventis
(OPTIONAL) Uncompensated Relationships - “Medical writing assistance for this abstract was provided by Bena Lim, PhD, CMPP, of Nucleus Global, an Inizio Company, and funded by F. Hoffmann-La Roche Ltd.” (Inst); “Medical writing assistance for this abstract was provided by Nimisha H. Bhoola, PhD, of Nucleus Global, an Inizio Company, and funded by F. Hoffmann-La Roche Ltd.” (Inst)
 
Nasser Altorki
Stock and Other Ownership Interests - Angiocrine Bioscience; tomorrow; View Point Medical
Research Funding - Regeneron
(OPTIONAL) Uncompensated Relationships - Nucleus Global
 
Achim Rittmeyer
Consulting or Advisory Role - AbbVie; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Daichi Sankyo; GlaxoSmithKline; Lilly; MSD; Novartis; Pfizer; Roche/Genentech
Speakers' Bureau - Bristol-Myers Squibb; Lilly; MSD; Roche/Genentech
(OPTIONAL) Uncompensated Relationships - Roche/Genentech
 
Tibor Csoszi
Consulting or Advisory Role - Novartis
Speakers' Bureau - Ipsen; Janssen-Cilag
Travel, Accommodations, Expenses - Pfizer; Sanofi
 
Ihor Vynnychenko
No Relationships to Disclose
 
Antonio Chella
No Relationships to Disclose
 
Velimir Gayevskiy
Employment - Genentech
 
Wei Zou
Employment - roche
Stock and Other Ownership Interests - roche
Research Funding - roche
Travel, Accommodations, Expenses - roche
 
Barbara Gitlitz
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Marcus Ballinger
Employment - Genentech
Stock and Other Ownership Interests - Roche
Patents, Royalties, Other Intellectual Property - co-inventor of an unpublished patent application (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
 
Elizabeth Bennett
Employment - Genentech/Roche
Stock and Other Ownership Interests - Roche/Genentech
(OPTIONAL) Uncompensated Relationships - Medical writing assistance for this abstract was provided by Nimisha H. Bhoola, PhD, of Nucleus Global, an Inizio Company, and funded by F. Hoffmann-La Roche Ltd. (Inst)
 
Barzin Nabet
Employment - Merck (I); Roche/Genentech
Stock and Other Ownership Interests - Merck (I); Roche/Genentech
Patents, Royalties, Other Intellectual Property - Patents related to immunomodulatory RNA and cancer immunotherapy biomarkers.
(OPTIONAL) Uncompensated Relationships - Genentech/Roche
 
Minu Srivastava
Employment - Genentech
Stock and Other Ownership Interests - Genentech
Travel, Accommodations, Expenses - Genentech